reports
Exactech Announces Completion of Merger with TPG Capital
GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech, Inc. (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, is pleased to announce the successful completion of the previously announced merger agreement with TPG Capital, pursuant to which TPG has acquired all of the issued and outstanding common stock of Exactech. In connection with the transaction, Exactech shareholders will receive $49.25 in cash for each share of Exactech common stock they hold (o...
Exactech Shareholders Approve Merger Agreement with TPG Capital
GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, today announced that at a Special Meeting of Shareholders held earlier today, Exactech’s shareholders approved the previously announced merger agreement with TPG Capital and certain of its affiliates, and approved the other two proposals described in Exactech’s proxy statement relating to today’s meeting. Approximately 94.5% of voting Exact...
EXACTECH (EXAC) INVESTOR ALERT - Andrews & Springer LLC is Seeking Mor...
WILMINGTON, Del.--(BUSINESS WIRE)-- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Exactech, Inc. (NASDAQGS: EXAC) (“Exactech” or the “Company”) relating to the sale of the Company to affiliates of private equity firm TPG Capital (“TPG”). On December 4, 2017, the two parties announced the signing of an amended merger agreement pursuant to which TPG will acquire Exacte...
EXACTECH (EXAC) SHAREHOLDER ALERT - Andrews & Springer LLC is Seeking ...
WILMINGTON, Del.--(BUSINESS WIRE)-- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Exactech, Inc. (NASDAQGS: EXAC) (“Exactech” or the “Company”) relating to the sale of the Company to affiliates of private equity firm TPG Capital (“TPG”). On December 4, 2017, the two parties announced the signing of an amended merger agreement pursuant to which TPG will acquire Exacte...
Exactech Announces Successful First Surgery with Vantage ® Total Ankl...
GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, hip, and knee, announced today the successful first surgery using its new Vantage® Total Ankle Mobile Bearing System, the newest addition to the Exactech extremities product line. Orthopaedic surgeon and Vantage Ankle design team member Professor Victor Valderrabano, MD, PhD, chairman of the Swiss Ortho Center Basel, recently performed the first case in the world with the mobile, ...
Exactech and TPG Capital Announce Amended Merger Agreement Providing f...
GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech, Inc. (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, announced today that it has entered into an amendment to its merger agreement with TPG Capital and certain of its affiliates which was previously announced on October 23, 2017. Pursuant to the amended merger agreement, the Company’s common stock outstanding immediately prior to the effective time of the merger (other than certain shares held b...
The Law Offices of Vincent Wong Reminds Investors of an Investigation ...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of Exactech, Inc. (NASDAQ:EXAC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to TPG Capital. Under the terms of the deal, Exactech shareholders will receive will receive $42 for each share of Exactech stock they own. Exactech founders Dr. Bill Petty and Betty Petty, as well as CEO David Petty, have agreed to vote their shares in favor of the merger. ...
Exactech Announces Successful First Revision Knee Replacement Surgery ...
GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, is pleased to announce that the first revision knee surgery was performed using the company's award-winning Truliant® instrumentation. Orthopaedic surgeons will have a chance to experience the Truliant primary and revision systems through live mechanical demonstrations Nov. 2-5 at the American Association of Hip and Knee Surgeons (AAHKS) Annual Meetin...
INVESTOR ALERT: Brower Piven Commences an Investigation into the Propo...
STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Exactech, Inc. (Nasdaq: EXAC) (“Exactech” or the “Company”) relating to the proposed buyout of Exactech by TPG Capital. Under the terms of the agreement, Exactech shareholders are anticipated to receive $42.00 in cash for each share of Exactech common stock held. The firm’s investi...
Exactech Q3 Revenue $61.4 Million
GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that revenue for the third quarter of 2017 increased 2% to $61.4 million from $59.9 million in the third quarter of 2016, and 2% on a constant currency basis. Domestic revenue increased 2% to $43.3 million, and international revenue increased 2% to $18.1 million in the third quarter of 2017. Diluted earnings per share for the third quar...
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Pr...
STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Exactech, Inc. (Nasdaq: EXAC) (“Exactech” or the “Company”) relating to the proposed buyout of Exactech by TPG Capital. Under the terms of the agreement, Exactech shareholders are anticipated to receive $42.00 in cash for each share of Exactech common stock held. The firm’s investi...
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of...
NEW YORK--(BUSINESS WIRE)-- Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of Exactech, Inc. (NASDAQ:EXAC) stockholders concerning the proposed acquisition of the company by TPG Capital. Our investigation concerns whether Exactech’s board of directors failed to adequately shop the Company and obtain the best possible value for its stockholders before entering into a definitive merger agreement with TPG Capital. Under the terms of the agreement, Exactech unitholders will receive $42, in cash, for each ...
The Law Offices of Vincent Wong Notifies Investors of an Investigation...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of Exactech, Inc. (NASDAQ:EXAC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to TPG Capital. Under the terms of the deal, Exactech shareholders will receive will receive $42 for each share of Exactech stock they own. Exactech founders Dr. Bill Petty and Betty Petty, as well as CEO David Petty, have agreed to vote their shares in favor of the merger. ...
Exactech Cancels Q3 Earnings Call Previously Scheduled for Tuesday, Oc...
GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that, due to its definitive agreement with TPG Capital to go private, the company will not hold the Third Quarter conference call previously scheduled for Tuesday, October 31, 2017. Exactech will report the results for the third quarter with a press release following the market close on Monday, October 30, 2017 as planned. ...
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investig...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Exactech, Inc. (“Exactech” or the “Company”) (NASDAQ:EXAC) stock prior to October 23, 2017. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Exactech to TPG Capital for $42 per share. Exactech founders Dr. Bill Petty and Betty Petty, as well as CEO David Petty, have agreed to vote their shares in favor of the me...
Exactech, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe I...
DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Exactech, Inc. (“Exactech”) (NasdaqGS: EXAC) concerning the acquisition by TPG Capital. Under the terms of the agreement, valued at approximately $625 million, Exactech shareholders will only receive $42.00 per Exactech share held. If you are an affected investor, and you want to learn more about the investigation or if you have information that you belie...
EXACTECH, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Inv...
WILMINGTON, Del.--(BUSINESS WIRE)-- Rigrodsky & Long, P.A.: Do you own shares of Exactech, Inc. (NASDAQ GS: EXAC)? Did you purchase any of your shares prior to October 23, 2017? Do you think the proposed buyout is fair? Do you want to discuss your rights? Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Exactech, Inc. (“Exactech” or the “Company”) (NASDAQ GS: EXAC) regarding pos...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Inve...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Exactech, Inc. (“Exactech” or the “Company”) (NASDAQ:EXAC) stock prior to October 23, 2017. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Exactech to TPG Capital for $42 per share. Exactech founders Dr. Bill Petty and Betty Petty, as well as CEO David Petty, have agreed to vote their shares in favor of the me...
Exactech Enters Definitive Agreement with TPG Capital to Go Private
GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, today announced that it has entered into a definitive merger agreement under which TPG Capital, the global private equity platform of alternative asset firm TPG, will acquire all of the outstanding shares of Exactech common stock. Exactech’s board of directors approved the agreement which provides for the payment of $42.00 per share in cash to all h...
Exactech Comments on Impact of Hurricanes Irma and Harvey; Adjusts Q3 ...
GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, said today it is adjusting guidance for the third quarter of 2017 as a result of the impact of Hurricanes Irma and Harvey. CEO and President David Petty said the estimated US revenue impact of the two hurricanes was approximately $1.2M to sales in Q3 across Florida, Texas, Georgia and the Carolinas. “We were fortunate that our ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.